Article Information
History
- May 10, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Natalia Martin Orozco, PhDa,*,
- Noah Vale, MDb,
- Alan Mihic, MDb,
- Talya Amor, BScb,
- Lawrence Reiter, PhDa,
- Yuko Arita, PhDa,
- Reuben Samson, BScc,d,
- Queenie Hu, PhDd,
- Anne-Claude Gingras, PhDc,d,
- Brad Sorenson, BSca,
- Eric G. Marcusson, PhDa and
- Piyush Patel, MDa,*
- aProvidence Therapeutics Holdings. 8832 Blackfoot Trail SE, Ste 120, Calgary, AB, T2J 3J1, Canada
- bLMC Manna Research-Toronto. 2291 Kipling Avenue, Unit 117B, Toronto, ON, M9W 4L6, Canada
- cDepartment of Molecular Genetics, University of Toronto. 1 King’s College Cir, Rm 4396, Toronto, ON, M5S 1A8, Canada
- dLunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health System, 600 University Ave, Toronto, ON M5G 1X5, Canada
- ↵*Corresponding Author:
Natalia Martin Orozco, PhD, Email:
natalia{at}providencetherapeutics.com, Phone:
647 554 8436
Posted May 10, 2022.
